Nater Dallafior Rechtsanwälte AG is now active in the life sciences space following the arrival of Claudia Götz Staehelin in March 2025. The team is particularly well-regarded for its expertise in contentious and regulatory matters.

Bär & Karrer Ltd. leverages its capabilities across the full range of healthcare and life sciences matters, including IP, licensing, R&D, M&A, patent litigation, investigations and related regulatory issues. Markus Schott routinely represents clients from across the industry in contentious administrative proceedings and also oversees governmental supervision and public procurement matters. Markus Wang heads the firm’s IP offering and provides advice on contentious and non-contentious patent issues. Dispute resolution expert Oliver M. Brupbacher acts in litigation, investigations and arbitration, as well compliance counselling and risk management mandates, often with a cross-border element. The three jointly lead the team. Djamila Batache is a name to note for questions of product liability and regulatory matters.

Homburger is adept at handling a broad array of matters within the healthcare and life sciences sector. The team has particular strengths in patent-related litigation, M&A, capital markets and licensing transactions, as well as financial restructurings of companies within the industry. Practice head Andri Hess leads the patent litigation side of the practice and also undertakes licensing contracts negotiations and other regulatory matters. Co-heads Daniel Häusermann and Richard Stäuber are also recommended. Häusermann advises on M&A, ECM and other financing transactions, while regulatory specialist Stäuber has extensive knowledge of both Siss and European competition law.

Kellerhals Carrard is well-placed to advise on the full gamut of regulatory, transactional and litigation matters affecting companies within the healthcare and life sciences sector, from clinical trials and regulatory approvals to business operations and M&A. The team is headed up by Claudio Helmle, Jörg von Manger-Koenig and Nicolas Mosimann. Helmle has a particular focus on product approvals and recalls within the pharmaceutical and biotech sectors, while von Manger-Koenig oversees compliance, regulatory and general management issues. Mosimann acts for clients in corporate and IP transactions as well as broader commercial law matters. Other key team members include regulatory expert Thomas Eichenberger and Virginie Rodieux, who oversees licensing agreements, R&D contracts and other IP issues.

Stefan Kohler and Matthias Staehelin spearhead the healthcare and life sciences offering at VISCHER. The team is well-versed in a broad array of matters, including patents and regulatory issues as well as M&A, financing rounds and advice for IPOs. Kohler is well-regarded for his knowledge of IP and technology law and counts a range of pharmaceutical and biotech companies amongst his clients. Staehelin is the firm’s key contact for transactional matters. Christian Wyss is an expert in licensing terms, patterning deals and fundraising, and also assists founders setting up new life sciences companies.

Bratschi Ltd is notable for its strong regulatory expertise. The pharma and healthcare group also has a wealth of experience advising on administrative, litigation, reimbursement and data protection issues, as well as on commercialisation and transactional matters. Practice head Felix Kesselring routinely represents clients before administrative authorities and courts. Marco Rizzi is recommended for transactional and corporate mandates, including cross-border disputes, while Yaël Heymann is an expert in regulatory protection matters.

Offering advice on the full spectrum of related matters, Lenz & Staehelin caters to clients across a broad range of sectors including biotech, pharmaceuticals, medical devices and healthcare providers. Key team members include dispute resolution expert Xavier Favre-Bulle, Andreas Rötheli and Guy Vermeil, who both handle transactional matters, and Thierry Calame, who specialises in IP issues. Stephan Erni’s diverse practice encompasses corporate and commercial issues, acquisitions and regulatory issues related to the launch of medical products in Switzerland. Harold Frey represents clients in international arbitrations and litigation proceedings before the Swiss courts.

MLL Legal fields a strong team of life sciences specialists and under the leadership of Nicola Benz and Simon Holzer, team is particularly noted for its expertise at the intersection of IP and regulatory law. The practice caters to pharmaceutical clients, innovative start-ups, medical devices companies and universities. Benz is an expert in technology and life sciences transactions, while Holzer is a key contact for IP litigation and regulatory issues. Ulrike Ciesla is well-versed in the technical side of pharmaceutical products and represents pharmaceutical companies before the Federal Patent Court. Louisa Galbraith is a further name to note for patent and trade mark disputes.

Philipp Haas and Janine Reudt-Demont spearhead the life sciences and healthcare offering at Niederer Kraft Frey Ltd. The team provides advice on a variety of related matters, from product launches to regulatory issues, and is particularly well-versed in large-scale M&A and other transactions. Reudt-Demont focuses on regulatory and compliance issues and she routinely acts for clients in court proceedings, arbitrations and mediations before administrative authorities. Haas oversees mandates involving public M&A deals, defence against hostile takeovers, and corporate governance.

Pestalozzi is well-regarded for its abilities across a wide spectrum of healthcare and life sciences mandates, from establishing production and distribution structures for regulated products, licensing transactions and IP rights to M&A, product liability and other regulatory issues. Franz Schubiger specialises in transactional, corporate and commercial matters. Lara Dorigo spearheads the firm’s IP offering and routinely handles life sciences disputes. Alongside his life sciences practice, Christian Roos offers advice on international trade law, contracts and employment matters. The three jointly lead the team. IP experts Sarah Drukarch and Alexandra Bühlmann are also recommended.

The team at Schellenberg Wittmer Ltd is best known for its abilities in dispute resolution, transactional matters and related regulatory issues within the life sciences sector. IP experts Philipp Groz and Lorenza Ferrari Hofer head up the Zurich offering while Stéphanie Chuffart-Finsterwald leads the team in Geneva. Groz handles a range of contractual and product liability disputes, routinely acting for clients in proceedings before Swiss courts and international arbitral panels. Hofer offers advice on regulatory and product liability issues, while Chuffart-Finsterwald tackles IP matters as well as R&D, compliance, data protection and dispute resolution mandates.

Michael Isler and Andreas Wildi are at the helm at Walder Wyss Ltd. , and the sizeable healthcare and life sciences team handles the full spectrum of relevant matters, although they are particularly noted for their regulatory expertise. Wildi’s diverse caseload encompasses pharmaceutical reimbursements and issues under pricing laws, as well as regulatory issues relating to pharmaceuticals, medical devices, cosmetics, genetic testing and stem cell and blood products. Isler has a wealth of experience in copyright, trade mark and patent law matters. Annemarie Lagger oversees advisory issues including contract drafting and also litigation, while Celine Weber is well-versed in pharmaceutical and medtech regulations.

Drawing on its international network, Baker McKenzie Switzerland SA offers expertise across the full range of issues affecting healthcare and life sciences companies, from M&A, reorganisations and carve-outs to licencing, regulatory compliance and IP matters. Olha Demianiuk heads up team alongside Julia Schieber. Demianiuk’s expertise lies in M&A transactions, while Schieber oversees IP transactions within the healthcare industry.

CMS von Erlach Partners Ltd. works alongside its international offices to leverage capabilities across a broad array of mandates within the healthcare and life sciences sector. Under the leadership of Christoph Willi and Patrick Sommer, the team regularly handles regulatory compliance challenges, appeal proceedings and related transactions, often with a cross-border dimension. Willi acts as a part-time judge in the Swiss Federal Patent Court, while Sommer specialises in regulatory issues, competition law and M&A transactions.

MME Legal | Tax | Compliance is well-placed to advise on the full gamut of healthcare and life sciences matters, including those relating to medicinal products, digital health, product regulation and most notably the medical usage of cannabis and psychedelic substances. Jonatan Baier leads the team and handles disputes and administrative proceedings as well as regulatory compliance and contractual issues. Daniel Haymann is also recommended for his experience in regulatory issues relating to cannabinoids and psychedelic compounds.

Sidley Austin LLP’s Geneva-based life sciences team leverages wide-ranging expertise across issues relating to all stages of the product lifecycle and caters to clients within the pharmaceutical, biotechnology, medical devices, novel foods and cosmetics industries. With prior experience at Swissmedic, Eva von Mühlenen heads up the practice and has extensive experience in both advisory and contentious regulatory matters. Tatjana Sachse advises on market access issues and international regulatory matters.

Valfor Attorneys-at-law has a strong presence in the healthcare sector, where the team provides advice on a broad range of legal issues, from M&A and public procurement projects to financing and contractual negotiations. Practice head Marc Metzger specialises in commercial and corporate law and handles transactional, public procurement and contractual matters. Co-head Christophe de Kalbermatten undertakes M&A and real estate projects. Hans-Peter Schwald, Andreas Suter and Stipe Jozic are also key members of the team.

Wenger Plattner counts hospitals, pharmaceutical companies, biotech companies and healthcare bodies amongst its clients. The life sciences and health law team offers its clients advice on regulatory issues, contract drafting and negotiations, as well as corporate matters. Tobias Meili steers the practice and specialises in corporate and commercial law, as well as M&A and banking and finance issues. Daniel Zimmerli primarily represents clients both in courts and before administrative authorities, while Carlo Conti advises on governmental, administrative, life sciences and health law.

The team at Wenger Vieli Ltd is particularly well-versed in market access, pricing and reimbursement matters, as well as marketing authorisations, including appeal proceedings before the Federal Office of Public Health and the Swiss courts. Frank Scherrer is at the helm and has extensive experience acting in contract negotiations, administrative and court proceedings, and also advises on transactional mandates. Beat Speck and Marc Walter are key contacts for corporate and M&A matters.